Needham: Maintaining the OncoCyte (OCX.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $3.60 to $4.25.
Needham：维持OncoCyte(OCX.US)评级，由买入调整至买入评级, 目标价由3.60美元调整至4.25美元。
Needham: Maintaining the OncoCyte (OCX.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $3.60 to $4.25.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.